Overview
- Reviews the most significant recent breakthroughs in anti-cancer drug discovery
- Highlights the medicinal chemistry that has delivered drugs or drug candidates
- Offers leading expertise provided by active researchers in each respective area
Part of the book series: Topics in Medicinal Chemistry (TMC, volume 28)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
This book reviews recent breakthroughs in anti-cancer drug discovery. Building on the previous volume in the series, it outlines some of the most significant developments that have occurred in the field in the subsequent period that have led to new drug approvals or promising clinical candidates. The volume is divided into chapters that each relate to a specific protein or protein class. Each chapter provides an overview of the underlying biology and then emphasises the medicinal chemistry strategies and tactics that led to the most significant drugs and drug candidates. A summary of clinical data and the future outlook for the field is also provided. Each chapter is authored by experts in the topic and who have themselves made significant contributions to their respective fields.
Editors and Affiliations
Bibliographic Information
Book Title: Cancer II
Editors: Michael J. Waring
Series Title: Topics in Medicinal Chemistry
DOI: https://doi.org/10.1007/978-3-319-75926-5
Publisher: Springer Cham
eBook Packages: Chemistry and Materials Science, Chemistry and Material Science (R0)
Copyright Information: Springer International Publishing AG, part of Springer Nature 2018
Hardcover ISBN: 978-3-319-75924-1Published: 13 November 2018
eBook ISBN: 978-3-319-75926-5Published: 25 January 2019
Series ISSN: 1862-2461
Series E-ISSN: 1862-247X
Edition Number: 1
Number of Pages: XIV, 475
Number of Illustrations: 150 b/w illustrations
Topics: Medicinal Chemistry, Cancer Research, Medical Biochemistry